154 related articles for article (PubMed ID: 20681445)
1. [Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid].
Liao H; Rao H; Zhang X; Lin Y; Jie M; Fu J; Long H; Rong T; Lin P
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):591-7. PubMed ID: 20681445
[TBL] [Abstract][Full Text] [Related]
2. [Surgical Resection and Prognosis of Bronchopulmonary Carcinoid].
Zhang S; Xue Z; Wen J; Wang B; Chu X
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):494-499. PubMed ID: 31451139
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung.
Yang Z; Wang Z; Duan Y; Xu S
Thorac Cancer; 2016 Nov; 7(6):633-638. PubMed ID: 27755793
[TBL] [Abstract][Full Text] [Related]
4. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
Laitinen KL; Soini Y; Mattila J; Pääkkö P
Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
[TBL] [Abstract][Full Text] [Related]
5. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
[TBL] [Abstract][Full Text] [Related]
7. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
8. [Histology does not accurately predict the clinical behaviour of bronchopulmonary carcinoids - results from an Icelandic population-based study].
Sigurdardottir JM; Isaksson HJ; Johannsson KB; Jonsson S; Gudbjartsson T
Laeknabladid; 2008 Feb; 94(2):125-30. PubMed ID: 18310777
[TBL] [Abstract][Full Text] [Related]
9. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
[TBL] [Abstract][Full Text] [Related]
11. [Surgically treated bronchopulmonary carcinoid tumours. Prognostic value of TNM staging 7a edition].
Patané AK; Poleri C; Martín C; Pupareli C; Rosales A; Rivero H; Rojas O; Rosenberg M
Medicina (B Aires); 2014; 74(6):437-42. PubMed ID: 25555002
[TBL] [Abstract][Full Text] [Related]
12. [Bronchopulmonary carcinoid tumors: Tunisian experience with 115 surgically treated cases].
Ayadi-Kaddour A; Marghli A; Zairi S; Zribi H; Ismail O; Braham E; Hantous-Zannad S; Kilani T; El Mezni F
Rev Pneumol Clin; 2015 Dec; 71(6):319-26. PubMed ID: 26195112
[TBL] [Abstract][Full Text] [Related]
13. Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis.
Santinelli A; Ranaldi R; Baccarini M; Mannello B; Bearzi I
Pathol Res Pract; 1999; 195(7):467-74. PubMed ID: 10448663
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometric evaluation of the Ki-67 proliferation rate and CD34 microvascular and D2-40 lymphovascular densities drives the pulmonary typical carcinoid outcome.
de Vilhena AF; das Neves Pereira JC; Parra ER; Balancin ML; Ab Saber A; Martins V; Farhat C; Abrantes MM; de Campos JRM; Tedde ML; Takagaki T; Capelozzi VL
Hum Pathol; 2018 Nov; 81():201-210. PubMed ID: 30031097
[TBL] [Abstract][Full Text] [Related]
15. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
Walts AE; Ines D; Marchevsky AM
Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
17. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and prognostic analyses of bronchopulmonary carcinoid tumors].
Dai W; Liu MJ; Zhang ZR; Mu JW; Sun KL; Cheng GY; Zhang RG; Wang DL
Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1321-3. PubMed ID: 24029481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
